- $224.24m
- $233.66m
- $41.04m
- 60
- 52
- 81
- 70
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Interest Income | |||||
Interest Expense | |||||
Net Interest Income | 48.1 | 52.6 | 57.9 | 65.2 | 54.4 |
Loan Loss Provision | |||||
Net Interest Income After Loan Loss Provision | 46.3 | 52.6 | 58.4 | 62.6 | 54.3 |
Non Interest Income | |||||
Non Interest Expense | |||||
Net Income Before Taxes | 20 | 19.7 | 28.2 | 31 | 4.23 |
Provision for Income Taxes | |||||
Net Income After Taxes | 15.8 | 15.5 | 21.9 | 25 | 3.82 |
Net Income Before Extraordinary Items | |||||
Net Income | 15.8 | 15.5 | 21.9 | 25 | 3.82 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 15.8 | 15.5 | 21.9 | 25 | 3.82 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.895 | 1.18 | 1.33 | 1.41 | 0.266 |